These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6104614)

  • 1. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
    Ryan RE
    Am Heart J; 1984 Oct; 108(4 Pt 2):1156-9. PubMed ID: 6148878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA; Crawford MH; O'Rourke RA
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
    Abengowe CU
    J Int Med Res; 1985; 13(2):116-21. PubMed ID: 2860041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B; Dahlqvist A; Raak A; Wrege U
    Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ; Brunton J; Sumner DJ
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
    Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
    Frithz G
    Curr Med Res Opin; 1978; 5(5):383-7. PubMed ID: 26519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):199S-203S. PubMed ID: 37875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol.
    Frick MH; Hartikainen M; Pörsti P
    Ann Clin Res; 1978 Apr; 10(2):105-6. PubMed ID: 28071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
    Levenson J; Simon AC; Moyse D; Bouthier J; Safar ME
    Am Heart J; 1984 Oct; 108(4 Pt 2):1177-82. PubMed ID: 6148882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of timolol and propranolol in essential hypertension.
    Lohmöller G; Frohlich ED
    Am Heart J; 1975 Apr; 89(4):437-42. PubMed ID: 234668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-blockers and arterial hypertension: comparison between nadolol and propranolol].
    Abate G; Polimeni RM; Di Peppe MC; Guarino F; Troja C; Marisi F; Cerritelli E; Brillante C; De Angelis M
    Clin Ter; 1982 Aug; 102(3):283-291. PubMed ID: 7140182
    [No Abstract]   [Full Text] [Related]  

  • 19. Advantages and benefits of once-daily nadolol treatment in hypertension.
    González D
    J Int Med Res; 1982; 10(5):351-6. PubMed ID: 6754507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of timolol versus propranolol on hypertension and hemodynamics.
    Aronow WS; Ferlinz J; Del Vicario M; Moorthy K; King J; Cassidy J
    Circulation; 1976 Jul; 54(1):47-51. PubMed ID: 6161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.